A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...

The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...

A cure for diabetes has been top of mind for many that live with the conditions under the term’s umbrella. But type 1 ...

The study found that making changes in one's lifestyle lowered the development of diabetes by 24 per cent. The same on taking ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

A new experimental drug meant to be taken just once a month could lead to “substantial weight reduction” within a year and help overcome both diabetes and obesity, a new clinical trial suggests.

Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the most promising effects of a new potential drug treatment for people with type ...

New diabetes drug may outperform Ozempic jab. The first diabetes and obesity pill that works like Ozempic — but in tablet form — may actually outperform the injectables drugs.